Mechanisms of evasion of the type i interferon antiviral response by flaviviruses

Journal of Interferon and Cytokine Research

Volumn 29, Issue 9, 2009, Pages 521-530

  Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON;

DRUG INHIBITION; FLAVIVIRUS; GENE INDUCTION; HUMAN; INFECTION CONTROL; MAMMAL CELL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

ANIMALS; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; INTERFERON TYPE I; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TOLL-LIKE RECEPTORS; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE;

FLAVIVIRUS; MAMMALIA; RNA VIRUSES;

EID: 70349263719     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0069     Document Type: Review

References (116)

1. Acosta EG, Castilla V, Damonte EB. 2008. Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. J Gen Virol 89(Pt 2):474-484. (Pubitemid 351622444)
2. Anderson JF, Rahal JJ. 2002. Effi cacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 8(1):107-108.
3. Arjona A, Ledizet M, Anthony K, Bonafe N, Modis Y, Town T, Fikrig E. 2007. West Nile Virus Envelope Protein Inhibits dsRNA-Induced Innate Immune Responses. J Immunol 179(12):8403-8409.
4. Best SM, Mitzel DN, Bloom ME. 2006. Action and reaction: the arthropod-borne fl aviviruses and host interferon response. Future Virol 1(4):447-459.
5. Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, Boer E, Wolfi nbarger JB, Bloom ME. 2005. Inhibition of interferon- stimulated JAK-STAT signaling by a tick-borne fl avivirus and identifi cation of NS5 as an interferon antagonist. J Virol 79(20):12828-12839.
6. Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, De Aguiar JB, Leon MA, Estes DM, Fayzulin R, Mason PW. 2007. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol 81:9100-9108. (Pubitemid 47311453)
7. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA. 2004. Structure of a fl avivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23(4):728-738. (Pubitemid 38425440)
8. Brinton MA. 2002. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol 56:371-402.
9. Brinton MA, Arnheiter H, Haller O. 1982. Interferon independence of genetically controlled resistance to fl aviviruses. Infect Immun 36(1):284-288.
10. Brooks TJ, Phillpotts RJ. 1999. Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes. Antiviral Res 41(1):57-64.
11. Chan YL, Chang TH, Liao CL, Lin YL. 2008. The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells. J Virol 82(21):10455-10464.
12. Chan-Tack KM, Forrest G. 2005. Failure of interferon alpha-2b in
13. Chang TH, Liao CL, Lin YL. 2006. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect 8(1):157-171.
14. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL. 2008. CLEC5A is critical for dengue- virus-induced lethal disease. Nature 453(7195):672-676.
15. Chung KM, Liszewski MK, Nybakken G, Davis AE, Townsend RR, Fremont DH, Atkinson JP, Diamond MS. 2006. West Nile virus non-structural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci USA 103(50):19111-19116. (Pubitemid 350002836)
16. Crance JM, Scaramozzino N, Jouan A, Garin D. 2003. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic fl aviviruses. Antiviral Res 58(1):73-79. (Pubitemid 36507224)
17. Daffi s S, Samuel MA, Keller BC, Gale M, Jr, Diamond MS. 2007. Cellspecifi c IRF-3 responses protect against West Nile virus infection by interferon-dependent and independent mechanisms. PLoS Pathog 3(7):e106.
18. Daffi s S, Samuel MA, Suthar MS, Gale M, Jr, Diamond MS. 2008a. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 82(21):10349-10358.
19. Daffi s S, Samuel MA, Suthar MS, Keller BC, Gale M, Jr, Diamond MS. 2008b. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 82(17):8465-8475.
20. Diamond MS, Harris E. 2001. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKRindependent mechanism. Virology 289(2):297-311. (Pubitemid 33141009)
21. Diamond MS, Roberts T, Edgil D, Lu B, Ernst J, Harris E. 2000. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74(11):4957-4966. (Pubitemid 30313834)
22. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303(5663):1529-1531. (Pubitemid 38314425)
23. Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B. 2002. An RNA cap (nucleoside-2-O-)-methyltransferase in the fl avivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 21(11):2757-2768. (Pubitemid 34619391)
24. Elshuber S, Allison SL, Heinz FX, Mandl CW. 2003. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J Gen Virol 84(Pt 1):183-191. (Pubitemid 36113564)
25. Evans JD, Seeger C. 2007. Differential Effects of Mutations in NS4B on WNV Replication and Inhibition of Interferon Signaling. J Virol 81:11809-11816. (Pubitemid 47623813)
26. Flamand M, Deubel V, Girard M. 1992. Expression and secretion of Japanese encephalitis virus nonstructural protein NS1 by insect cells using a recombinant baculovirus. Virology 191(2):826-836. (Pubitemid 23022487)
27. Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, Deubel V. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylationdependent fashion. J Virol 73(7):6104-6110. (Pubitemid 29274901)
28. Fredericksen BL, Gale M, Jr. 2006. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol 80(6):2913-2923.
29. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M, Jr. 2008. Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 82(2):609-616.
30. Fredericksen BL, Smith M, Katze MG, Shi PY, Gale M. 2004. The host response to West Nile virus infection limits spread through the activation of the interferon regulatory factor 3 pathway. J Virol 78(14):7737-7747. (Pubitemid 38915920)
31. Gale M, Jr, Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436(7053):939-945. (Pubitemid 41191669)
32. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, Filali-Mouhim A, Moser JM, Mehta RS, Drake DR, III, Castro E, Akondy R, Rinfret A, Yassine-Diab B, Said EA, Chouikh Y, Cameron MJ, Clum R, Kelvin D, Somogyi R, Greller LD, Balderas RS, Wilkinson P, Pantaleo G, Tartaglia J, Haddad EK, Sekaly RP. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205(13):3119-3131.
33. Gilfoy FD, Mason PW. 2007. West Nile virus-induced IFN production is mediated by the double-stranded RNA-dependent protein kinase, PKR. J Virol 81(20):11148-11158. (Pubitemid 47536087)
34. Gitlin L, Barchet W, Gilfi llan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103(22):8459-8464.
35. Gollins S, Porterfi eld J. 1986a. The uncoating and infectivity of the fl avivirus West Nile on interaction with cells: effects of pH and ammonium chloride. J Gen Virol 67(Pt 9):1941-1950.
36. Gollins SW, Porterfi eld JS. 1986b. pH-dependent fusion between the fl avivirus West Nile and liposomal model membranes. J Gen Virol 67(Pt 1):157-166.
37. Guirakhoo F, Heinz FX, Mandl CW, Holzmann H, Kunz C. 1991. Fusion activity of fl aviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol 72(Pt 6):1323-1329.
38. Guo JT, Hayashi J, Seeger C. 2005. West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 79(3):1343-1350. (Pubitemid 40459081)
39. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specifi c recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303(5663):1526-1529. (Pubitemid 38314424)
40. Ho LJ, Hung LF, Weng CY, Wu WL, Chou P, Lin YL, Chang DM, Tai TY, Lai JH. 2005. Dengue virus type 2 antagonizes IFNalpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol 174(12):8163-8172. (Pubitemid 40806328)
41. Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, Block TM, Guo JT. 2008. Identifi cation of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82(4):1665-1678. (Pubitemid 351206918)
42. Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M. 2005. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 79(9):5414-5420. (Pubitemid 40548209)
43. Julander JG, Morrey JD, Blatt LM, Shafer K, Sidwell RW. 2007. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antiviral Res 73(2):140-146. (Pubitemid 46135771)
44. Kalil AC, Devetten MP, Singh S, Lesiak B, Poage DP, Bargenquast K, Fayad P, Freifeld AG. 2005. Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis 40(5):764-766. (Pubitemid 40381356)
45. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441(7089):101-105.
46. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M, Jr. 2006. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fi tness and virulence. J Virol 80(19):9424-9434.
47. Keller BC, Johnson CL, Erickson AK, Gale M, Jr. 2007. Innate immune evasion by hepatitis C virus and West Nile virus. Cytokine Growth Factor Rev 18(5-6):535-544.
48. Khromykh AA, Sedlak PL, Guyatt KJ, Hall RA, Westaway EG. 1999. Effi cient trans complementation of the fl avivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J Virol 73(12):10272-10280.
49. Kimura T, Gollins SW, Porterfi eld JS. 1986. The effect of pH on the early interaction of West Nile virus with P388D1 cells. J Gen Virol 67(Pt 11):2423-2433.
50. Kong KF, Delroux K, Wang X, Qian F, Arjona A, Malawista SE, Fikrig E, Montgomery RR. 2008. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 82(15):7613-7623. (Pubitemid 352031228)
51. Krishnan MN, Sukumaran B, Pal U, Agaisse H, Murray JL, Hodge TW, Fikrig E. 2007. Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol 81(9):4881-4885. (Pubitemid 46668686)
52. Leyssen P, Drosten C, Paning M, Charlier N, Paeshuyse J, De Clercq E, Neyts J. 2003. Interferons, interferon inducers, and interferonribavirin in treatment of fl avivirus-induced encephalitis in mice. Antimicrob Agents Chemother 47(2):777-782. (Pubitemid 36158114)
53. Leyssen P, Van Lommel A, Drosten C, Schmitz H, De Clercq E, Neyts J. 2001. A novel model for the study of the therapy of fl avivirus infections using the modoc virus. Virology 279(1):27-37. (Pubitemid 34160996)
54. Li H, Gade P, Xiao W, Kalvakolanu DV. 2007. The interferon signaling network and transcription factor C/EBP-beta. Cell Mol Immunol 4(6):407-418.
55. Lin CW, Cheng CW, Yang TC, Li SW, Cheng MH, Wan L, Lin YJ, Lai CH, Lin WY, Kao MC. 2008. Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42. Virus Res 137(1):49-55.
56. Lin RJ, Chang BL, Yu HP, Liao CL, Lin YL. 2006. Blocking of interferon- induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol 80(12):5908-5918.
57. Lin RJ, Liao CL, Lin E, Lin YL. 2004. Blocking of the alpha interferoninduced Jak-Stat signaling pathway by Japanese Encephalitis Virus. J Virol 78(17):9285-9294.
58. Lindenbach BD, Rice CM. 1997. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 71(12):9608-9617. (Pubitemid 39096538)
59. Lindenbach BD, Rice CM. 2001. Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams & Wilkins. pp 991-1041.
60. Liu WJ, Chen HB, Wang XJ, Huang H, Khromykh AA. 2004. Analysis of adaptive mutations in kunjin virus replicon RNA reveals a novel role for the fl avivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 78(22):12225-12235. (Pubitemid 39458742)
61. Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA. 2006. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/ beta interferon induction and attenuates virus virulence in mice. J Virol 80(5):2396-2404. (Pubitemid 43271545)
62. Lobigs M, Mullbacher A, Wang Y, Pavy M, Lee E. 2003. Role of type I and type II interferon responses in recovery from infection with an encephalitic fl avivirus. J Gen Virol 84(Pt 3):567-572. (Pubitemid 36267129) (Pubitemid 36267129)
63. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez- Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82(1):335-345.
64. Mackenzie JM, Khromykh AA, Jones MK, Westaway EG. 1998. Subcellular localization and some biochemical properties of the fl avivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 245(2):203-215.
65. Mackenzie JM, Khromykh AA, Parton RG. 2007. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2(4):229 239.
66. Mahajan VS, Drake A, Chen J. 2009. Virus-specifi c host miRNAs: antiviral defenses or promoters of persistent infection Trends Immunol 30(1):1-7.
67. Malet H, Egloff MP, Selisko B, Butcher RE, Wright PJ, Roberts M, Gruez A, Sulzenbacher G, Vonrhein C, Bricogne G, Mackenzie JM, Khromykh AA, Davidson AD, Canard B. 2007. Crystal structure of the RNA polymerase domain of the West Nile virus nonstructural protein 5. J Biol Chem 282(14):10678-10689. (Pubitemid 47093413) (Pubitemid 47093413)
68. Mashimo T, Lucas M, Simon-Chazottes D, Frenkiel MP, Montagutelli X, Ceccaldi PE, Deubel V, Guenet JL, Despres P. 2002. A nonsense mutation in the gene encoding 2-5-oligoadenylate synthetase/ L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 99(17):11311-11316. (Pubitemid 34920922)
69. Matsumoto M, Funami K, Oshiumi H, Seya T. 2004. Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol 48(3):147 154. (Pubitemid 38405076)
70. Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA. 2008. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J Virol 82(11):5212-5219. (Pubitemid 351705230)
71. Meurs EF, Watanabe Y, Kadereit S, Barber GN, Katze MG, Chong K, Williams BR, Hovanessian AG. 1992. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol 66(10):5804-5814.
72. Miller JL, deWet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, Rudd PM, Gordon S. 2008. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4(2):e17.
73. Miller S, Kastner S, Krijnse-Locker J, Buhler S, Bartenschlager R. 2007. The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J Biol Chem 282(12):8873-8882. (Pubitemid 47093477)
74. Miller S, Sparacio S, Bartenschlager R. 2006. Subcellular localization and membrane topology of the Dengue virus type 2 Nonstructural protein 4B. J Biol Chem 281(13):8854-8863. (Pubitemid 43847992)
75. Modis Y, Ogata S, Clements D, Harrison SC. 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature 427(6972):313-319. (Pubitemid 38133652)
76. Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW. 2004. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother 15(2):101-109.
77. Mukhopadhyay S, Kuhn RJ, Rossmann MG. 2005. A structural perspective of the fl avivirus life cycle. Nat Rev Microbiol 3(1):13-22. (Pubitemid 40028466)
78. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A. 2005. Inhibition of alpha/ beta interferon signaling by the NS4B protein of fl aviviruses. J Virol 79(13):8004-8013. (Pubitemid 40853504)
79. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia- Sastre A. 2003. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 100:14333-14338. (Pubitemid 37499237)
80. Murthy HM, Judge K, DeLucas L, Padmanabhan R. 2000. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for fl aviviral polyprotein processing and drug design. J Mol Biol 301(4):759-767. (Pubitemid 30706804)
81. Park GS, Morris KL, Hallett RG, Bloom ME, Best SM. 2007. Identifi cation of residues critical for the interferon antagonist function of langat virus NS5 reveals a role for the RNAdependent RNA polymerase domain. J Virol 81(13):6936-6946.
82. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. 2007. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449(7164):919-922. (Pubitemid 47598616) (Pubitemid 47598616)
83. Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA. 2002. Positional cloning of the murine fl avivirus resistance gene. Proc Natl Acad Sci USA 99(14):9322-9937. (Pubitemid 34764612)
84. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferonmediated signalling. Nat Rev Immunol 5(5):375-386.
85. Platanias LC, Uddin S, Domanski P, Colamonici OR. 1996. Differences in Interferon and signalling. J Biol Chem 271(39):23630-23633.
86. Purtha WE, Chachu KA, Virgin HWT, Diamond MS. 2008. Early B-cell activation after West Nile virus infection requires alpha/ beta interferon but not antigen receptor signaling. J Virol 82(22):10964-10974.
87. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203(2):413-424.
88. Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. 2004. Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis 190(6):1084-1087. (Pubitemid 39186794)
89. Rivieccio MA, Suh HS, Zhao Y, Zhao ML, Chin KC, Lee SC, Brosnan CF. 2006. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol 177(7):4735-4741. (Pubitemid 44469807)
90. Robertson SJ, Mitzel DN, Taylor RT, Best SM, Bloom ME. 2009. Tickborne fl aviviruses: dissecting host immune responses and virus countermeasures. Immunol Res 43(1-3):172-186.
91. Roosendaal J, Westaway EG, Khromykh A, Mackenzie JM. 2006. Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi traffi cking of the NS4A protein. J Virol 80(9):4623-4632.
92. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454(7203):523-527.
93. Samuel MA, Diamond MS. 2005. Type I IFN protects against lethal West Nile Virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79(21):13350-13361.
94. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BRG, Silverman RH, Gale M, Diamond MS. 2006. PKR and RNAse L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 80(14):7009-7019. (Pubitemid 44025199)
95. Scherbik SV, Paranjape JM, Stockman BM, Silverman RH, Brinton MA. 2006. RNase L plays a role in the antiviral response to West Nile virus. J Virol 80(6):2987-2999. (Pubitemid 43346394)
96. Scholle F, Mason PW. 2005. West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Virology 342(1):77-87. (Pubitemid 41531987)
97. Schroder M, Bowie AG. 2005. TLR3 in antiviral immunity: key player or bystander Trends Immunol 26(9):462-468.
98. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. 2004. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-celldependent immunity are less critical. J Virol 78(6):2701-2710. (Pubitemid 38314329)
99. Solomon T, Dung NM, Wills B, Kneen R, Gainsborough M, Diet TV, Thuy TT, Loan HT, Khanh VC, Vaughn DW, White NJ, Farrar JJ. 2003. Interferon alfa-2a in Japanese encephalitis: a randomized double-blind placebo-controlled trial. Lancet 361(9360):821-826. (Pubitemid 36331845)
100. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
101. Stephen EL, Sammons ML, Pannier WL, Baron S, Spertzel RO, Levy HB. 1977. Effect of a nuclease-resistant derivative of polyriboinosinic- polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis 136(1):122-126.
102. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25(3):373-381.
103. Takeuchi O, Akira S. 2007. Recognition of viruses by innate immunity. Immunol Rev 220:214-224.
104. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, Zhuang X, Smit JM. 2008. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4(12):e1000244.
105. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, Wilschut J, Zhuang X, Smit JM. 2007. Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81(21):12019-12028. (Pubitemid 47623832)
106. Wang JP, Liu P, Latz E, Golenbock DT, Finberg RW, Libraty DH. 2006. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177(10):7114-7121. (Pubitemid 44715079)
107. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10(12):1366-1373. (Pubitemid 40022719)
108. Wang X, Hinson ER, Cresswell P. 2007. The interferon-inducible protein viperin inhibits infl uenza virus release by perturbing lipid rafts. Cell Host Microbe 2(2):96-105. (Pubitemid 47209520)
109. Werme K, Wigerius M, Johansson M. 2008. Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling. Cell Microbiol 10(3):696-712. (Pubitemid 351194096)
110. Wilson JR, de Sessions PF, Leon MA, Scholle F. 2008. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol 82(17):8262-8271.
111. Xu T, Sampath A, Chao A, Wen D, Nanao M, Chene P, Vasudevan SG, Lescar J. 2005. Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A. J Virol 79(16):10278-10288. (Pubitemid 41098569)
112. Yap TL, Xu T, Chen YL, Malet H, Egloff MP, Canard B, Vasudevan SG, Lescar J. 2007. Crystal structure of the dengue virus RNAdependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol 81(9):4753-4765. (Pubitemid 46668672) (Pubitemid 46668672)
113. Yusof R, Clum S, Wetzel M, Murthy HM, Padmanabhan R. 2000. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem 275(14):9963-9999 (Pubitemid 30202042)
114. Zhang Y, Burke CW, Ryman KD, Klimstra WB. 2007. Identifi cation and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81(20):11246-11255. (Pubitemid 47536097)
115. Zhou A, Hassel BA, Silverman RH. 1993. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72(5):753-765. (Pubitemid 23093883)
116. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH. 1997. Interferon action and apoptosis are defective in mice devoid of 2,5-oligoadenylate- dependent RNase L. EMBO J 16(21):6355-6363. (Pubitemid 27483262)